News

Drug Discovery: Current Trends in Medicinal Chemistry

Webcast with Live Q&A
Sign up for our FREE April virtual webcast on Drug Discovery: Trends in Medicinal Chemistry.
Dr. Walter Moos will lead a roundtable discussion with four experts from the biomedical industry on the challenges, pitfalls and opportunities in drug discovery today. Specific topics of discussion include:
  • How well do lead-finding technologies work compared to classical medicinal chemistry techniques?
  • What potential is there for products such as peptides, proteins, antibodies and RNA-based therapies in light of the fact that nearly all the most prescribed therapeutics remain small molecule drugs?
  • What is the optimal balance of in-house R&D vs. outsourced work (e.g., CROs) throughout the drug discovery process?
  • How can industry build more symbiotic partnerships with academia?
Panelists will answer audience questions live at the end of the panel discussion; you can submit a question when registering or via the chat room or Twitter during the broadcast.
Date: Thursday, April 26, 2018
Time: 2:30 – 4:00 ET Moderator:

  • Walter H. Moos, PhD, ShanghaiPharma
    and University of California, San Francisco

Panelists:

  • Gina Xiaojing Wang, PhD, Genentech, Inc.
  • Dmitry O. Koltun, PhD, Gilead Sciences, Inc.
  • Chudi Ndubaku, PhD, Aduro Biotech, Inc.
  • Eric B. Harstad, PhD, Theravance Biopharma
In the 1980s, if a medicinal chemist made one compound a week, that was a star chemist. With the advent of combinatorial chemistry in the 1990s and now techniques like DNA-encoded libraries, you’re talking billions of compounds.
– Walter H. Moos, PhD

 

Please forward this email to your colleagues in pharma and biotech!

Event Site: bit.ly/VKSdrugdisc or virtual.keystonesymposia.org
Event hashtag: #VKSdrugdisc